Marc Chimowitz

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial
    Marc I Chimowitz
    Department of Neurosciences, Stroke Center, Medical University of South Carolina, Charleston, USA
    J Stroke Cerebrovasc Dis 20:357-68. 2011
  2. ncbi Stenting versus aggressive medical therapy for intracranial arterial stenosis
    Marc I Chimowitz
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
    N Engl J Med 365:993-1003. 2011
  3. ncbi Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
    Bruce Ovbiagele
    Stroke Center, Department of Neurology, UCLA Medical Center, Los Angeles, CA, USA
    Neurology 66:1344-9. 2006

Research Grants

Detail Information

Publications3

  1. ncbi Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial
    Marc I Chimowitz
    Department of Neurosciences, Stroke Center, Medical University of South Carolina, Charleston, USA
    J Stroke Cerebrovasc Dis 20:357-68. 2011
    ....
  2. ncbi Stenting versus aggressive medical therapy for intracranial arterial stenosis
    Marc I Chimowitz
    Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
    N Engl J Med 365:993-1003. 2011
    ..However, PTAS has not been compared with medical management in a randomized trial...
  3. ncbi Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
    Bruce Ovbiagele
    Stroke Center, Department of Neurology, UCLA Medical Center, Los Angeles, CA, USA
    Neurology 66:1344-9. 2006
    ..The authors evaluated the prevalence and prognosis of the MetS among individuals with symptomatic intracranial arterial stenosis...

Research Grants10

  1. WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSIS
    Marc Chimowitz; Fiscal Year: 2002
    ..e., greater than or equal to 6 percent per year) to justify a subsequent trial comparing intracranial angioplasty with best medical therapy in these patients. ..